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cartilage-like tissue. The autologous engineered cartilage 
spheroids demonstrate a rapid adhesion and integration on/in 
human osteoarthritic artilage. 
Conclusions: Our approach allows for the first time the autoge- 
nous in vitro engineering of cartilage tissue that is particularly 
suitable for the regeneration of cartilage tissue in osteoarthritis as 
well as an in vitro pharmacological test system to analyze patho- 
genesis and therapeutics in osteoarthritis. 
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REGULATION OF HUMAN TYPE II COLLAGEN (COL2A1) 
EXPRESSION BY TRANSFORMING GROWTH FACTOR-b1 IN 
RABBIT ARTICULAR CHONDROCYTES 
• C Chedjichristos, C Ghayor, J-F Herrouin, J-P Pujol, P Galera 
Laboratory of Connective Tissue Biochemist~ Faculty of 
Medicine, 14032 CAEN Cedex, France 
Aim: TGF-~I effect on collagen type II expression in cultured 
chondrocytes depends on whether the cells are confluency- 
arrested or in a proliferating state. The aim of this work was to 
determine the sequence of the promoter and the transcription 
factors which are responsible for the TGF~I -induced inhibition of 
COL2A1 expression in proliferating cells. 
Methods: Rabbit articular chondrocytes (RAC) were used in pri- 
mary cultures, at about 80% of confluency. Semi-quantitative RT- 
PCR was used to determine steady-state levels of collagen type 
II. Constructs containing deletions in the promoter and/or first 
intron regions of COL2A1, fused to the luciferase reporter, were 
transfected in RAC, with or without 10% fetal calf serum. Dnase 
I footprint and gel retardation analysis were also performed. A 
vector containing the cDNA of a hybrid TGF-~I receptor (T~RII/I), 
acting as a dominant negative, has been used to verify the 
specificity of effects. 
Results: TGF-~I inhibited COL2AI gene expression via a region 
of 63 bp upstream the transcription start site. When RAC were 
cotransfected with the TBRII/I vector, the transcriptional ctiviy of 
all the COL2A1 constructs was increased, in the presence or 
absence of serum. Dnase I footprint and gel retardation analysis 
of the 63 bp showed that TGF-131-induced inhibition on COL2A1 
expression involves a multimeric omplex in which Spl and Sp3 
play a major role. 
Conclusions: Despite that TGF-131 is generally considered as a 
potent stimulant of matrix synthesis in most tissues, it exerts an 
inhibition on type II collagen expression by proliferating chondro- 
cytes, through a 63 bp sequence of the promoter which binds the 
transcription factors Spl and Sp3. This mechanism may play 
some role in the early phase of OA, when chondrocytes start 
dividing. It may participate to the reduction of collagen type II, 
a process associated with production of non specific type I 
collagen, reflecting the phenotype alteration of these cells. 
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GLUCOSAMINE HCL AND CHONDROITIN SULFATE INHIBIT 
THE CATABOLIC RESPONSE OF ARTICULAR CARITLAGE 
EXPLANTS CULTURED WITH LIPOPOLYSACCHARIDE 
M. W. Orth, T. L. Peters, J. N. Hawkins 
Department of Animal Science, Michigan State University 
East Lansing, MI, USA 
Aim: The aim of this research was to determine at what concen- 
trations glucosamine (GLN) and chondroitin sulfite (CS) would 
inhibit the cytokine-induced catabolic response in articular 
cartilage explants. 
Methods: Articular cartilage was obtained from carpal joints of 
either steers or horses. Cartilage discs (3.5 ram) were biopsied 
and three discs -were cultured per well of a 24-well culture plate. 
After 2 days of equilibration, explants were incubated with 10 
~.g/ml of lipopolysaccharide (LPS) in the presence of varying con- 
centrations of GLN (FCHG49TM) *, CS ('I'RH122TM) * or both. 
Control treatments included explants with no LPS, and LPS with- 
out GLN or CS. Media were collected daily and analyzed for nitric 
oxide (NO) and keratan sulfate (equine only). Cartilage extracts 
were analyzed for gelatinolytic activity using gel zymography. 
Activity was quantitated using scanning densitometry. Extracts 
from equine cartilage were also analyzed for MMP-13. 
Results: GLN as low as 1 mg/ml decreased NO production in 
LPS-stimulated explants. In 3 of 4 experiments the addition of 
either 0.25 or 0.50 mg/ml CS did not further decrease NO pro- 
duction. In equine cartilage, 1 mg/ml of GLN decreased MMP-13 
concentrations with no benefit from the addition of CS. Keratan 
sulfate in media (indicator of proteoglycan degradation) was max- 
imally decreased in the presence of GLN and CS. Gelatinolytic 
activity was suppressed predominantly by CS. 
Conclusions: Overall, the most consistent combination for pre- 
venting the catabolic response in the explants was 1 mg/ml GLN 
and 0.25 mg/ml CS. GLN was effective at inhibiting NO and 
MMP-I 3 production, both of which are activated via the NFk-~ 
pathway; whereas CS inhibited proteolytic activity. Thus, the two 
appear to complement one another in preventing the catabolic 
response in LPS-stimulated cartilage explants. 
*Trademarks for Nutramax Laboratories, NC., Edgewood, MD 
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GLYCERYL TRINITRATE INCREASES SUBCHONDRAL BONE 
THICKNESS AND DENSITY IN AN OVINE MENISCECTOMY 
MODEL OF OSTEOARTHRITIS 
MA Cake, RA Read, S-Y Hwa*, P Ghosh* 
Division of Veterinary and Biomedical Sciences, 
Murdoch University, Perth, Australia; 
*Institute of Bone and Joint Research, Royal North Shore 
Hospital, Sydney, Australia 
Aim: To examine the effect of glyceryl trinitrate (GTN), a nitric 
oxide (NO) donor compound, on the concurrent progression of 
subchondral bone changes in an aged ovine model of osteo- 
arthritis (OA). 
Methods: Bilateral ateral meniscectomy was performed on 12 
seven-year-old Merino ewes to induce OA. Six were treated with 
GTN twice per week, applied topically as 2% ointment (0.7 
mg/kg) (OA+GTN). Six other sheep were used as non-operated 
controls (NOC). After sacrifice at 6 months, the subchondral bone 
(SCB) density (BMD) of the lateral and medial femoral condyles 
(LFC, MFC) and tibial plateaus (LTP, MTP) was assessed by 
DEXA. Histological sections of the central weight-bearing region 
of each region were analyzed using image analysis software to 
measure the thickness of the SCB in the inner, middle, and outer 
zones of each region. 
Results: OA SCB thickness and BMD increased in the lateral 
compartment, and decreased in the medial compartment. 
OA+GTN displayed significantly greater SCB thickness relative to 
OA in the middle (in-contact) zone of the LFC (1.721 vs 1.271 mm, 
p = 0.024; NOC = 0.904) and the outer zone of the MFC (0.652 vs 
0.484 mm, p = 0.049; NOC= O.665). SCB density was greater in 
OA+GTN than in OA in the LFC (1.158 vs t.057 g m/cm 2, p = 
0.036; NOC = 0.934), LTP (1.031 vs 0.923 gm/cm.Z, p = 0.018; 
NOC = 0.830) and MTP (0.862 vs 0.772 gm/cm 2,  p = 0.014; 
NOC = 0.932). 
Conclusions: Treatment with GTN increased SCB thickness and 
density during CA. NO inhibits osteoclastic bone resorption in 
vitro, and NO-donors have been shown to increase bone density 
elderly women. High BMD has been associated with CA, whilst 
subchondral bone sclerosis is a histological hallmark of CA 
and is suspected by some to be central to its pathogenesis. 
The results of this study suggest that NO may be an important 
mediator of the SCB changes seen in CA, and provides evidence 
that clinical use of NO donor compounds, such as GTN, may 
contribute to disease progression in CA. 
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BIOLOGICAL ACTION OF HYALURONAN ON HUMAN 
ARTICULAR CHONDROCYTES: THE IMPORTANCE OF 
MOLECULAR WEIGHT 
Emilia Maneiro, M Carmen de Andres Maria J. Lopez-Armada, 
Jose Antonio Pinto, Jose L. Fernanclez-Sueiro, Beatriz Lema, 
*Francisco Javier de Toro,*Fausto Galdo, Francisco J Blanco 
Laboratorio de Investigacion. Servicio de Reumatologia, Hospita/ 
Juan Canalejo. *Departamento de Medicina. Universidade da 
Coruna, A Coruna-Spain 
Introduction: Hyaluronan.(HA) is a glycosaminoglycan (GAG) 
which is present in synovial fluid and the extracellular cartilage 
matrix (ECM). HA is viscoelastic and concentration of HA in CA 
synovial fluid (SF) is lower than normal SF. Original use of intra- 
articular (IA) HA in CA was to increase the viscosity of SF. Clinical 
effects with IA HA prolong the life of HA in the joint. These find- 
ings can not be explained only by the biomechanical properties. 
Aims: To analyze the biological effects of HA on NO and 
PGE2 synthesis, and on chondrocyte apoptosis. To study the 
importance of the molecular weight of HA on these biological 
effects. 
Material and Methods: Cells were isolated from cartilage 
obtained from joint replacement in CA patients. Chondrocytes 
(75 000 cell/well) were cultured for 24h to detect PGE2 or 48 
hours to measure NO, afterwards they were pre-incubated with 
HA and stimulated with IL-1 5 ng/ml. We have used an HA of low 
molecular weight (HALMW): Hyalgan® (500-730 kDa, Bioiberica 
S.A.) and another HA of high molecular weight (HAHMW): 
Synvisc® (6,000 kDa, Biomatrix Inc), at the following concentra- 
tions: 10 10 ~.g/ml; 50 Xg/ml; 100 ~.g/ml; 150 ~.g/ml and 200 
~g/ml. NO was detected by Greiss reaction and PGE2 was quan- 
tified by a commercial EIA (Amersham) in supernatant. Apoptosis 
was induced by an NO donor and the effect of HA on apoptosis 
was quantified by flow cytometry. 
Results: Both HAs studied do not have any effect on basal pro- 
duction of NO or PGE2. However, HALMW at 200 Xg/ml reduces 
by 70% the NO synthesis and by 45% the synthesis of PGE2 
induced by IL-1. HAHMW does not modify the levels of NO or 
PGE2 induced by IL-1. Both HAs at 200 mg/ml decrease the 
apoptosis induced by NO (HALMW by 40% and HAHMW by 3 
6%). 
Conclusion: In this study, the analysis in chondrocyte of two HAs 
has evidenced that different HAs have different effects. Therefore, 
we can state that molecular weight influences some of the 
biological effects that this molecule has on human articular 
chondrocytes. 
Supported by Bioiberica, S. A., Barcelona, Spain and Universidad 
da coruna, Spain. 
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EFFECTS OF ELASTOVISCOUS SUBSTANCES ON THE 
MECHANOSENSITIVITY OF ARTICULAR PAIN RECEPTORS 
A Gomis*, M Pawlak**, R F Schmidt* **, C Belmonte* 
*lnstituto de Neurociencias, Universidad Miguel 
Hemandez-CSIC, Alicante, Spain and **Physiologisches Institut 
der Universitat Wuczburg, Wurzburg, Germany 
Aim: Elastoviscous hyaluronan solutions reduce articular pain in 
humans and impulse activity of nociceptors ('pain receptors') in 
experimental animals. The aim of this work was to compare the 
effects of commercial viscoelastic substances with different 
molecular weights on the discharges of joint nociceptors evoked 
by movement of the inflamed rat knee joint. 
Methods: Electrical activity of single fibers innervating the knee 
joint was recorded from fine filaments of the median articular 
nerve of anesthetized rats. Knee joint inflammation was produced 
by intraarticular injection of kaolin and carrageenan. Mechanical 
stimulation consisted in controlled rotations of the knee joint 
within and outside its normal working range, for 10 s every 5 mm. 
Solutions of sodium hyaluronan of different molecular weights 
(MW) (<1,000,000 and <2,000,000) and of the high molecular 
weight (v 6,000,000) hyaluronan derivative hylan G-F 20 were 
injected into the joint cavity (0.05 ml). Impulse discharges 
evoked by the movements were compared before and after 
injection. 
Results: Hylan G-F 20 significantly reduced in the course of 1 
hour the number of nerve impulses evoked by movements to 
about 60 % of the control frequency. MW <2,000,000 hyaluronan 
solutions had a slightly faster (around 30 min) and weaker, but still 
significant effect (reduction to 75% of the control impulse fre- 
quency); MW <1,000,000 hyaluronan solutions did not decrease 
significantly the mean impulse frequency of movement-evoked 
discharges in pain nerve fibers. 
Conclusions: It has been proposed that hyaluronan-derived 
elastoviscous ubstances used for the treatment of articular pain 
act as a viscoelastic filter, reducing the transmission of stretch to 
pain nerve terminals in the joint. High molecular weight hylan 
solutions were more effective than lower molecular weight 
hyaluronan solutions in reducing nerve discharges of pain fibers. 
Thus, it is to be expected that high MW hylan solutions Will have 
more pronounced analgesic effects on human joint pain than 
hyaluronan solutions of lower MW. 
Supported by Genzyme Biosurgery, USA and SAF 99-0066-C02- 
01, Spain. 
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HUMAN SERUM IS SUPERIOR TO FETAL CALF SERUM FOR 
ISOLATING AND ESTABLISHING MONOLAYERS OF HUMAN 
ARTICULAR CHONDROCYTES 
A Panasyuk ~.2, A Barbara 1, G Colantuoni 1,3, M Quinterol, 3, 
DR Mitrovic 1 
IlNSERM 349, Paris, France; Institut of Rheumatology, RAMS, 
Moscow, Russia; 2Department of Rheumatology, University 
Hospital of L.A., Merida, Venezuela 
The presence of serum is indispensable for growing many cell 
types culture. Fetal calf serum (FCS) is commonly used for estab- 
lishing monolayers of articular chondrocytes (AC) and is consid- 
ered as the best source of factors promoting cell growth. The 
development of techniques of chondrocytes' grafting on dam- 
aged articular surfaces has stressed in recent years a need for the 
use of human serum (HS) for preparing and cultivating human AC. 
